Vitamin E News
Bryce Edmonds

Evidence is mounting for vitamin E’s Alzheimer’s-battling properties. Researchers from the University of Kentucky, Lexington, found that vitamin E helped block the toxic effects of an animal-based form of amyloid beta peptide, which is a primary constituent of senile plaques, thought to be one of the main causative factors in Alzheimer’s disease. In the study, published in the Journal of Alzheimer’s Disease in October, researchers found that the rodent version of the peptide was found to have a “significant effect on neuronal DNA fragmentation, loss of neurotic networks and cell viability.” The antioxidant vitamin E inhibited the pathways for these damaging effects.

Earlier this year, researchers from Johns Hopkins University reported in the Archives of Neurology that large doses of vitamin E and vitamin C supplements used in combination “reduced the prevalence and incidence” of Alzheimer’s disease.

Meanwhile, ingredient supplier Archer Daniels Midland announced that it would begin supplying no genetically modified, natural-source vitamin E to the market in early 2005. Changes to European Union labeling laws have recently declared that anything derived from a GM source must be declared as such, and pressures from EU consumers are creating a growing demand for the non-GM version. Non-GM vitamin E has been very difficult to source, and quantities will still be limited and pricey.